Clinical Trial

A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)

Name: A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008) — clinical trial record (NCT07743151)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this trial is to compare what happens to MK-1406 in the body of healthy participants when it is given as 2-injections and 3-injections. Researchers also want to learn about the safety of MK-1406 and if people tolerate it.

Trial Details

NCT Number	NCT07743151
Lead Sponsor	Merck Sharp & Dohme LLC
Conditions	Healthy
Enrollment	400 participants
Start Date	2026-09-15
Primary Completion	2027-02-05 (estimated)
Study Completion	2027-02-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-03